πŸ‡ΊπŸ‡Έ FDA
Patent

US 10479786

Protein kinase inhibitors

granted A61KA61K31/506A61K45/06

Quick answer

US patent 10479786 (Protein kinase inhibitors) held by Princeton Drug Discovery, Inc expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Princeton Drug Discovery, Inc
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/506, A61K45/06, A61P, A61P25/28